To understand the effects of PROTAC on the early stages (within 24 h) of drug‐induced dedifferentiation in melanoma, we profiled the expression and activity of key transcription factors and receptor tyrosine kinases that effect a dedifferentiation program in treated cells (Figure 3A). This evidence concerns the gene NTRK1 and melanoma.